TimesSquare Capital Management »

Rapt Therapeutics shares owned by TimesSquare Capital Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by TimesSquare Capital Management from 13F filings

Historical chart of TimesSquare Capital Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by TimesSquare Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by TimesSquare Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 504k 24.85

More positions owned by TimesSquare Capital Management

Cintas Corporation (CTAS)
Cyber-ark Software SHS (CYBR)
O'reilly Automotive (ORLY)
Hexcel Corporation (HXL)
Crowdstrike Holdings Cl A (CRWD)
Bj's Wholesale Club Holdings (BJ)
Gartner (IT)
AmerisourceBergen (COR)
Chemed Corp Com Stk (CHE)
Waste Connections (WCN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Smartsheet Com Cl A (SMAR)
Cheniere Energy Com New (LNG)
Veeva Systems Cl A Com (VEEV)
Dex (DXCM)

View all positions for TimesSquare Capital Management

Top funds holding Rapt Therapeutics

T. Rowe Price Associates
Column Group
Perceptive Advisors
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Kingdon Capital Management
Samlyn Capital
Euclidean Capital
Alphabet
TimesSquare Capital Management
Cormorant Asset Management
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Braidwell

View all funds holding Rapt Therapeutics